| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011581884 |
| P356 | DOI | 10.1007/S12026-013-8385-Z |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s12026-013-8385-z |
| P698 | PubMed publication ID | 23371837 |
| P5875 | ResearchGate publication ID | 235392556 |
| P50 | author | Mª Ángeles Muñoz-Fernández | Q40088018 |
| P2093 | author name string | Mirko Zimic | |
| Martiniano Bello | |||
| Miguel Quiliano | |||
| Jose Correa-Basurto | |||
| Verónica Briz | |||
| R Campos-Rodríguez | |||
| S Rojas-Hernández | |||
| Luis Tolentino-López | |||
| Paola Kinara Reyes Loyola | |||
| P2860 | cites work | Immunoblot analysis of IgA antibodies to Naegleria fowleri in human saliva and serum | Q72994754 |
| Molecular dynamics simulations of a protein-protein dimer: particle-mesh Ewald electrostatic model yields far superior results to standard cutoff model | Q78125613 | ||
| Software news and updates. Carma: a molecular dynamics analysis program | Q80135906 | ||
| Homology modeling of the structure of acyl coA:isopenicillin N-acyltransferase (IAT) from Penicillium chrysogenum. IAT interaction studies with isopenicillin-N, combining molecular dynamics simulations and docking | Q84417497 | ||
| Comparison of the mutation rates of human influenza A and B viruses | Q24542982 | ||
| Rates of spontaneous mutation among RNA viruses | Q24563020 | ||
| The SWISS-MODEL Repository and associated resources | Q24656047 | ||
| CEP: a conformational epitope prediction server. | Q24813120 | ||
| Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6 | Q27640454 | ||
| Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants | Q27650620 | ||
| The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site | Q27664598 | ||
| Elicitation of structure-specific antibodies by epitope scaffolds | Q27664711 | ||
| Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
| All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
| VMD: visual molecular dynamics | Q27860554 | ||
| The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling | Q27860637 | ||
| Scalable molecular dynamics with NAMD | Q27860718 | ||
| Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
| Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets | Q28474889 | ||
| The influenza viruses. | Q30358132 | ||
| Pandemic vaccines: promises and pitfalls. | Q30358149 | ||
| ElliPro: a new structure-based tool for the prediction of antibody epitopes | Q30373719 | ||
| Evidence for cross-species infections and cross-subtype mutations in influenza a matrix proteins. | Q30385159 | ||
| Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase | Q30385853 | ||
| MHC class II epitope predictive algorithms. | Q30388353 | ||
| Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates | Q30393205 | ||
| Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus | Q30400133 | ||
| Molecular dynamics of proteorhodopsin in lipid bilayers by solid-state NMR. | Q30400711 | ||
| Pandemic novel 2009 H1N1 influenza: what have we learned? | Q30406262 | ||
| Demand for care and nosocomial infection rate during the first influenza AH1N1 2009 virus outbreak at a referral hospital in Mexico City. | Q30407990 | ||
| Optimizing substitution matrix choice and gap parameters for sequence alignment | Q30939790 | ||
| NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculations | Q30950498 | ||
| STRAP: editor for STRuctural Alignments of Proteins | Q30986215 | ||
| Model for the peptide-free conformation of class II MHC proteins | Q33342783 | ||
| Structural and thermodynamic approach to peptide immunogenicity | Q33385988 | ||
| High-throughput engineering and analysis of peptide binding to class II MHC | Q33630225 | ||
| Hidden Markov model speed heuristic and iterative HMM search procedure | Q33662738 | ||
| The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9. | Q33772455 | ||
| Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes | Q33781091 | ||
| Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes | Q33786803 | ||
| Ligand supported homology modeling and docking evaluation of CCR2: docked pose selection by consensus scoring | Q33787996 | ||
| Live bivalent vaccine for parainfluenza and influenza virus infections | Q33788756 | ||
| Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach | Q33959944 | ||
| pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes | Q34160241 | ||
| Computer aided selection of candidate vaccine antigens | Q34312517 | ||
| Influenza virus neuraminidase: structure, antibodies, and inhibitors | Q34318113 | ||
| Antigenicity and immunogenicity of synthetic peptides | Q34535909 | ||
| Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18 | Q35072448 | ||
| Rules for peptide binding to MHC class II molecules. | Q36675121 | ||
| An improved relaxed complex scheme for receptor flexibility in computer-aided drug design | Q36838120 | ||
| Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. | Q37091294 | ||
| The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase | Q37831369 | ||
| Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses | Q39773935 | ||
| The antigenic structure of proteins: a reappraisal. | Q40076398 | ||
| Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses | Q40632706 | ||
| Several common HLA-DR types share largely overlapping peptide binding repertoires | Q41052906 | ||
| Molecular dynamics simulations and functional characterization of the interactions of the PAR2 ectodomain with factor VIIa | Q41909739 | ||
| Molecular modeling of class I and II alleles of the major histocompatibility complex in Salmo salar | Q43909373 | ||
| Application of machine learning techniques in predicting MHC binders. | Q45964605 | ||
| Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted response | Q46125924 | ||
| Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis. | Q50785562 | ||
| Evaluation of synthetic peptides of WbSXP-1 for the diagnosis of human lymphatic filariasis. | Q50786845 | ||
| Evaluation of primary and secondary responses to a T-cell-dependent antigen, keyhole limpet hemocyanin, in rats. | Q50939391 | ||
| ProPred: prediction of HLA-DR binding sites. | Q52049897 | ||
| Barnase thermal titration via molecular dynamics simulations: detection of early denaturation sites. | Q52566474 | ||
| Restoration of specific immunological virginity. | Q53986904 | ||
| Protein Modeling by E-mail | Q57075450 | ||
| T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance | Q68940743 | ||
| Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure | Q68955504 | ||
| Mapping epitopes on a protein antigen by the proteolysis of antigen-antibody complexes | Q68961886 | ||
| Use of the averaged mutation rate in pieces of protein sequences to predict the location of antigenic determinants | Q69050900 | ||
| Aromatic side-chain interactions as the origin of immunological diversity in the TyrTyrGluGlu and TyrGluTyrGlu epitopes: NMR and fluorescence evidence | Q72090537 | ||
| Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. Antibodies to a D-enantiomer do recognize the parent L-hexapeptide and reciprocally | Q72639495 | ||
| Topographic antigenic determinants recognized by monoclonal antibodies to sperm whale myoglobin | Q72659641 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 44-60 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Immunologic Research | Q15754981 |
| P1476 | title | Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts | |
| P478 | volume | 56 |
| Q30372843 | A continuous peptide epitope reacting with pandemic influenza AH1N1 predicted by bioinformatic approaches. |
| Q89724780 | Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies |
| Q39959606 | Energetic and flexibility properties captured by long molecular dynamics simulations of a membrane-embedded pMHCII-TCR complex |
| Q34973944 | Molecular dynamics simulations to provide insights into epitopes coupled to the soluble and membrane-bound MHC-II complexes |
| Q41187810 | Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase. |
| Q42159681 | Predicting peptide vaccine candidates against H1N1 influenza virus through theoretical approaches. |
| Q42672591 | Structural and functional characterization of the divergent Entamoeba Src using Src inhibitor-1. |
| Q95642155 | Structural and molecular analyses of functional epitopes and escape mutants in Japanese encephalitis virus envelope protein domain III |
| Q30370942 | Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study. |
Search more.